HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized insights, ...

HeartBeam's FDA clearance for its cable-free at-home 12-lead ECG marks a pivotal step toward commercialization and broader cardiac-care adoption.

HeartBeam shares rise after FDA clears its 12-lead ECG software, boosting plans for a 2026 launch and expanded cardiac ...

HeartSciences Inc.(Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT” ...

HeartBeam (Nasdaq:BEAT) announced today that it received FDA 510(k) clearance for its 12-lead electrocardiogram (ECG) ...

Fitbit only just launched its ECG feature on the Fitbit Sense, but the health tracking specialist is already working on the next iteration of the technology. The company confirmed to Wareable that it ...

ECG technology in wearables is a fairly new feature and Fitbit is among the brands that offers it in at least one product. But it seems that Fitbit didn’t stop there as it’s apparently working on a ...

DOYLESTOWN, Pa., Aug. 16, 2021 /PRNewswire/ — assisTek, a boutique eSource company known for providing customized solutions to support clinical trial teams for two and a half decades, has collaborated ...

Austin, Texas, United States, December 10th, 2025, FinanceWire HeartBeam (NASDAQ: BEAT), a medical technology company focused ...